Entries by Carme Lopez

Laboratorios Salvat leads the development of the first treatment for otomycosis

18/02/2020 in , , /by

The research, currently underway both in the United States of America and Europe, will involve an investment of more than $10 million. The worldwide launch of the new medicament to treat this type of external otitis, expected for the end of 2021, reinforces Salvat’s positioning in otology at an international level. The company’s international business […]

Salvat and Pharmaloop were present at the CPhI Worldwide 2019

19/11/2019 in , , /by

On the 5th, 6th and 7th of November, the city of Frankfurt hosted one of the largest events worldwide in the pharmaceutical industry, bringing together over 45,000 visiting attendees and 2,500 international exhibitors: CPhI Worldwide 2019. Salvat and Pharmaloop teams held numerous meetings with current and potential partners from all over the world of the […]

Salvat was present at The Bio International Convention 2019, at Philadelphia, US.

25/06/2019 in , , /by

Salvat was present at the world’s largest pharmaceutical biotechnology event: The Bio International Convention 2019, which took place this year in Philadelphia (USA), from June 3rd to 6th, where meetings were held with companies from the pharmaceutical industry from all over the world. The aim was to explore new business opportunities for licensing our products and […]

Salvat and Pharmaloop participated in the CPhI Worldwide Congress

16/10/2018 in , , /by

Salvat and Pharmaloop participated in the CPhI Worldwide Congress, which annually gathers the most important companies in the pharmaceutical world. This year it was held in Madrid, where both companies had the opportunity to hold many meetings with other pharmaceutical companies to explore opportunities that allow us to increase our activities internationally.  

Laboratorios Salvat has participated in the consortium created for the development of the INDREYE research project “Innovative solutions for the treatment and diagnosis of dry eye syndrome”

11/10/2018 in /by

Laboratorios Salvat has participated in the consortium created for the development of the INDREYE research project “Innovative solutions for the treatment and diagnosis of dry eye syndrome” funded by the Spanish National Program of Public-Private Cooperation, subprogram INNPACTO, 2012 call. This program is co-financed by the European Union through the European regional development fund (ERDF/FEDER).

Laboratorios SALVAT maintains the rating of ‘VERY GOOD’ in the PROFARMA call in 2018

12/09/2018 in /by

On July 26, 2018, the Spanish Ministry of Industry, Commerce and Tourism, through the General Secretariat of Industry and Small and Medium Enterprises resolved to grant Laboratorios Salvat its classification within Group A: Companies with significant research activity with own pharmaceutical production plant or its own basic or preclinical R & D center, with the […]

Laboratorios Salvat was represented at the 2018 BIO International Convention

13/06/2018 in /by

Salvat was part of the most important International Biotechnology congress, which was held at the Boston Convention Center (Massachusetts, USA) from July 4 to 7, 2018. BIO is a unique opportunity for companies in the pharmaceutical industry to establish relationships of scientific and commercial nature, as well as close deals and explore further collaborations with […]